参考文献/References:
1 Bedard G, Wong E, Goh P, et al. Handbook of Bone Metastases (2nd edition) [M]. Toronto, Bayer HealthCare Pharmaceuticals Inc, 2014, 3-5.
2 Cheung FH. The practicing orthopedic surgeon’s guide to managing long bone metastases [J]. Orthop Clin NorthAm, 2014, 45(1): 109-119.
3 Weber KL, Randall RL, Grossman S, et al. Management of lower-extremity bone metastasis [J]. J Bone Joint Surg Am, 2006, 88(suppl 4): 11-19.
4 Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity [J]. Clin Cancer Res, 2006, 12(20 Pt 2): 6243s- 6249s.
5 Roodman GD. Mechanisms of bone metastases [J]. N Engl J Med, 2004, 350(16): 1655-1664.
6 eI-Khoury GY, Dalinka MK, Alazraki N, et al. Metastatic bone disease. America College of Radiology. ACR Appropriateness Criteria [J]. Radiology, 2000, 215: 283-293.
7 Yang Y, Ma Y, Sheng J, et al. A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China [J]. Chin J Cancer, 2016, 35(1): 40.
8 Yong M, Jensen AÖ, Jacobsen JB, et al. Survival in breast cancer patients with bone metastases and skeletal-related events: a populationbased cohort study in Denmark (1999-2007) [J]. Breast Cancer Res Treat, 2011, 129(2): 495-503.
9 Sathiakumar N, Delzell E, Morrisey MA, et al. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population- based analysis of US Medicare beneficiaries, 1999-2006 [J]. Prostate Cancer Prostatic Dis, 2011, 14(2): 177-183.
10 Forsberg JA, Eberhardt J, Boland PJ, et al. Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network [J]. PLoS One, 2011, 6(5): e19956.
11 Ratasvuori M, Wedin R, Hansen BH, et al. Prognostic role of en-bloc resection and late onsetof bone metastasis in patients with bone-seeking carcinomas ofthe kidney,breast,lung,and prostate:SSG study on 672 operatedskeletal metastases [J]. J Surg Oncol, 2014, 110(4): 360- 365.
12 Coleman R, Body JJ, Aapro M, et al. Bone health in cancer patients: ESMO clinical practice guidelines [J]. Ann Oncol, 2014, 25(Suppl 3): iii124-137.
13 Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010, 127(12): 2893-2917.
14 Li S, Peng Y, Weinhandl ED, et al. Estimated number of prevalent cases of metastatic bone disease in the US adult population [J]. Clin Epidemiol, 2012, 4: 87-93.
15 Siegel R, Ma JM, Zou ZH, et al. Cancer statistics, 2014 [J]. CA Cancer J Clin, 2014, 64(1): 9-29.
16 Chen WQ, Zheng RS, Zeng HM, et al. The updated incidences and mortalities of major cancers in China, 2011 [J]. Chin J Cancer, 2015, 34(3): 502-507.
17 Ruggieri P, Mavrogenis AF, Casadei R, et al. Protocol of surgical treatment of long bone pathological fractures [J]. Injury, 2010, 41 (11): 1161-1167.
18 Ward WG, Holsenbeck S, Dorey FJ, et al. Metastatic disease of the femur: surgical treatment [J]. Clin Orthop Relat Res, 2003, 415(Suppl):S230-S244.